• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

No­vo Nordisk to phase out its pro­duc­tion of hu­man in­sulin pens glob­al­ly

5 months ago
Manufacturing

Zai Lab aims to raise $200M; Kro­nos Bio to seek ‘strate­gic’ op­tions

5 months ago
News Briefing

As blue­bird projects more com­mer­cial de­mand, the biotech con­tin­ues to seek cash

5 months ago
Pharma
Cell/Gene Tx

BeiGene will re­brand to BeOne Med­i­cines, drop­ping name's link to Chi­na roots

5 months ago
China
Pharma

Mer­ck KGaA’s life sci­ence unit is still feel­ing the Covid de­mand de­cline

5 months ago
Pharma
Manufacturing

Mer­ck buys in­to PD-1/VEGF space as Sum­mit comes for Keytru­da

5 months ago
Deals
China

Ex­clu­sive: As­cid­i­an CEO Michael Ehlers leaves Ap­ple Tree Part­ners for MPM BioIm­pact

5 months ago
People
Startups

GSK makes case for Blenrep's re­turn with new blood can­cer sur­vival da­ta

5 months ago
R&D

FDA ap­proves PTC’s ul­tra-rare dis­ease gene ther­a­py for broad­er pa­tient pop­u­la­tion than Eu­rope

5 months ago
Pharma
Cell/Gene Tx

Dan­ish biotech Gubra touts ear­ly weight loss da­ta in hot amylin field

5 months ago
R&D

Drug in­spec­tor at­tri­tion leads to 'many few­er' checks than 2016 peak, GAO says

5 months ago
FDA+
Manufacturing

J&J takes 340B fight with fed­er­al gov­ern­ment to court

5 months ago
Pharma
Law

89bio’s $125M of­fer­ing; An­oth­er FDA hold for Kezar

5 months ago
News Briefing

Adap­ti­m­mune's sec­ond T cell re­cep­tor cell ther­a­py for rare sar­co­mas pass­es piv­otal test

5 months ago
R&D
Cell/Gene Tx

Pri­ma­ry care uni­corn start­up For­ward Health shuts down

5 months ago
Health Tech

Met­sera rais­es $215M for stud­ies of GLP-1 and amylin obe­si­ty drugs

5 months ago
Financing
Startups

Ot­su­ka and ICU Med­ical forge IV man­u­fac­tur­ing net­work to sup­ply the US

5 months ago
Deals
Manufacturing

Af­ter stock slides, Am­gen ad­dress­es bone den­si­ty talk on obe­si­ty drug

5 months ago
R&D
Pharma

TRexBio rais­es $84M to take in-house im­mune pro­gram in­to the clin­ic

5 months ago
Financing

Ex­clu­sive: Flag­ship names two CEO-part­ners to lead Va­lo Health, Apri­ori Bio

5 months ago
People
Startups

New can­cer class heats up as BioN­Tech buys out Chi­na part­ner and its PD-L1/VEGF drug

5 months ago
Deals
China

Sy­ros' shares plum­met as blood can­cer drug fails again

5 months ago
R&D

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

5 months ago
Pharma

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

5 months ago
China
Pharma
First page Previous page 65666768697071 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.